Wall Street brokerages expect Molina Healthcare, Inc. (NYSE:MOH) to report sales of $4.55 billion for the current quarter, according to Zacks. Eight analysts have issued estimates for Molina Healthcare’s earnings, with the highest sales estimate coming in at $4.62 billion and the lowest estimate coming in at $4.47 billion. Molina Healthcare reported sales of $4.95 billion in the same quarter last year, which would suggest a negative year-over-year growth rate of 8.1%. The business is scheduled to report its next quarterly earnings results on Monday, February 11th.

On average, analysts expect that Molina Healthcare will report full year sales of $18.78 billion for the current financial year, with estimates ranging from $18.66 billion to $18.86 billion. For the next fiscal year, analysts forecast that the company will post sales of $17.20 billion, with estimates ranging from $16.74 billion to $18.06 billion. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Molina Healthcare.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, October 31st. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.90. The firm had revenue of $4.70 billion for the quarter, compared to analysts’ expectations of $4.72 billion. Molina Healthcare had a return on equity of 30.50% and a net margin of 1.27%. The business’s revenue for the quarter was down 6.6% compared to the same quarter last year. During the same period in the previous year, the firm posted ($1.62) EPS.

Several equities research analysts have recently commented on MOH shares. Morgan Stanley upped their price objective on Molina Healthcare from $132.00 to $178.00 and gave the stock an “overweight” rating in a research note on Wednesday, September 5th. Piper Jaffray Companies raised their price objective on Molina Healthcare to $165.00 and gave the company an “overweight” rating in a research report on Wednesday, September 26th. Zacks Investment Research lowered Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Monday, October 8th. Evercore ISI started coverage on Molina Healthcare in a research report on Tuesday, October 9th. They set an “in-line” rating and a $158.00 price objective for the company. Finally, Jefferies Financial Group lowered Molina Healthcare from a “buy” rating to a “hold” rating and set a $152.00 price objective for the company. in a research report on Friday, October 12th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $131.92.

Shares of NYSE:MOH traded down $4.13 during midday trading on Tuesday, hitting $132.38. The company had a trading volume of 14,211 shares, compared to its average volume of 742,628. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.40 and a quick ratio of 1.40. The firm has a market capitalization of $8.73 billion, a price-to-earnings ratio of 238.09, a price-to-earnings-growth ratio of 1.52 and a beta of 1.53. Molina Healthcare has a 12-month low of $71.07 and a 12-month high of $154.06.

In related news, Director Ronna Romney sold 200 shares of the stock in a transaction dated Monday, December 3rd. The shares were sold at an average price of $141.23, for a total value of $28,246.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider James Woys purchased 25,000 shares of the stock in a transaction that occurred on Wednesday, September 19th. The stock was acquired at an average cost of $148.79 per share, with a total value of $3,719,750.00. Following the acquisition, the insider now owns 17,203 shares in the company, valued at approximately $2,559,634.37. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 9,045 shares of company stock valued at $1,172,076. 0.65% of the stock is owned by insiders.

Large investors have recently made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Molina Healthcare by 14.0% during the third quarter. Vanguard Group Inc. now owns 5,773,626 shares of the company’s stock worth $858,538,000 after acquiring an additional 709,776 shares during the period. Legal & General Group Plc increased its holdings in Molina Healthcare by 13.5% during the third quarter. Legal & General Group Plc now owns 87,850 shares of the company’s stock valued at $13,063,000 after buying an additional 10,431 shares during the period. Kepos Capital LP purchased a new position in Molina Healthcare during the third quarter valued at approximately $711,000. New Mexico Educational Retirement Board increased its holdings in Molina Healthcare by 29.6% during the third quarter. New Mexico Educational Retirement Board now owns 14,430 shares of the company’s stock valued at $2,146,000 after buying an additional 3,300 shares during the period. Finally, TIAA CREF Investment Management LLC increased its holdings in Molina Healthcare by 8.2% during the third quarter. TIAA CREF Investment Management LLC now owns 888,660 shares of the company’s stock valued at $132,144,000 after buying an additional 67,069 shares during the period.

About Molina Healthcare

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Read More: Marijuana Stocks Investing Considerations

Get a free copy of the Zacks research report on Molina Healthcare (MOH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.